Abstract
Background: Obesity-associated low-grade inflammation at white adipose tissue (WAT) leads to metabolic defects. Sex steroid hormone estrogen may be protective against high-fat diet (HFD)-induced obesity and insulin resistance. This has been tested by many previous studies utilizing rodent models of ovariectomy (OVX) and/or treatment of estradiol (E2), the major biologically active form of estrogen. Body weight and adiposity are increased by OVX and reduced following E2 treatment, however. Thus, the protective roles of E2 may be secondary effects to the changes in body weight and adiposity. We hypothesize that E2 directly prevents inflammation and maintains insulin sensitivity in WAT independent of energy status using mice with similar body weights and adiposity.
Materials and methods: Four groups of female C57BL/6 mice were used, including sham-operated mice treated with vehicle for E2 and fed with either a low-fat diet (LFD; Sham-Veh-LFD) or a HFD (Sham-Veh-HFD), and HFD-fed OVX mice treated with either vehicle (OVX-Veh-HFD) or E2 (OVX-E2-HFD). Body weight and abdominal parametrial WAT mass, insulin signaling, and expression levels of genes related to low-grade inflammation in WAT were compared between these groups pair-fed with equal amounts of calories for a period of 4 days.
Results: Body weights and WAT mass were similar in all four groups. OVX-Veh-HFD mice had impaired insulin signaling associated with rapid activation of inflammation, whereas OVX-E2-HFD group maintained insulin sensitivity without showing inflammation in WAT.
Conclusions: E2 directly contributed to the maintenance of insulin sensitivity during the early phase of development of metabolic dysfunction, possibly via preventing low-grade inflammation in WAT.
Acknowledgments
This study was supported by Sigma Xi Grant-in-Aid of Research (MS), Madalene and George Shetler Diabetes Research Award (HS), and R15 NIDDK090823 (HS).
References
1. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Ann Rev Med 2003;54:453–71.10.1146/annurev.med.54.101601.152403Search in Google Scholar
2. Alberti K, Zimmet P, Shaw J. IDF epidemiology task force consensus group: the metabolic syndrome — a worldwide definition. Lancet 2005;366:1059–62.10.1016/S0140-6736(05)67402-8Search in Google Scholar
3. French SA, Story M, Jeffery RW. Environmental influences on eating and physical activity. Annu Rev Publ Health 2001;22:309–35.10.1146/annurev.publhealth.22.1.309Search in Google Scholar PubMed
4. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 2006;331:166–74.10.1097/00000441-200604000-00002Search in Google Scholar PubMed
5. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112: 1796–808.10.1172/JCI200319246Search in Google Scholar
6. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821–30.10.1172/JCI200319451Search in Google Scholar
7. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991;40:1397–403.10.2337/diab.40.11.1397Search in Google Scholar PubMed
8. Lee YS, Li P, Huh JY, Hwang IJ, Lu M, Kim JI, Ham M, Talukdar S, Chen A, Lu WJ, Bandyopadhyay GK, Schwendener R, Olefsky J, Kim JB. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 2011;60:2474–83.10.2337/db11-0194Search in Google Scholar PubMed PubMed Central
9. Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, Wielinga PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, Cnubben N, Evelo C, van Ommen B, Kooistra T. Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS ONE 2010;5:e8817.10.1371/journal.pone.0008817Search in Google Scholar PubMed PubMed Central
10. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72: 1150–62.10.1172/JCI111040Search in Google Scholar PubMed PubMed Central
11. Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Arterioscler Thromb Vasc Biol 1997;17:64–71.10.1161/01.ATV.17.1.64Search in Google Scholar
12. Frias JP, Macaraeg GB, Ofrecio J, Yu JG, Olefsky JM, Kruszynska YT. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 2001;50:1344–50.10.2337/diabetes.50.6.1344Search in Google Scholar
13. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745–9.10.2337/diacare.28.11.2745Search in Google Scholar
14. Crespo CJ, Smit E, Snelling A, Sempos CT, Andersen RE. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 2002;25: 1675–80.10.2337/diacare.25.10.1675Search in Google Scholar
15. Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, Bush TL. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Diabetes Care 1998;21:1589–95.10.2337/diacare.21.10.1589Search in Google Scholar
16. Saglam K, Polat Z, Yilmaz M, Gulec M, Akinci S. Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 2002;18:211–4.10.1385/ENDO:18:3:211Search in Google Scholar
17. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL. Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J Clin Endocrinol Metab 2006;91:3404–10.10.1210/jc.2006-0614Search in Google Scholar PubMed
18. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial. Diabetologia 2004;47:1175–87.10.1007/s00125-004-1448-xSearch in Google Scholar PubMed
19. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006;8:538–54.10.1111/j.1463-1326.2005.00545.xSearch in Google Scholar PubMed
20. Rochira V, Madeo B, Zirilli L, Caffagni G, Maffei L, Carani C. Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men. Diabetic Med 2007;24:1491–5.10.1111/j.1464-5491.2007.02304.xSearch in Google Scholar PubMed
21. Louet JF, LeMay C, Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 2004;6:180–5.10.1007/s11883-004-0030-9Search in Google Scholar PubMed
22. Kumagai S, Holmäng A, Björntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 1993;149:91–7.10.1111/j.1748-1716.1993.tb09596.xSearch in Google Scholar PubMed
23. Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, Onishi T, Sugiura T, Shizuta Y. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 2003;176:237–46.10.1677/joe.0.1760237Search in Google Scholar PubMed
24. Bryzgalova G, Lundholm L, Portwood N, Gustafsson JÅ, Khan A, Efendic S, Dahlman-Wright K. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab 2008;295:E904–12.10.1152/ajpendo.90248.2008Search in Google Scholar PubMed PubMed Central
25. Smith U, Axelsen M, Carvalho E, Eliasson B, Jansson PA, Wesslau C. Insulin signaling and action in fat cells: Associations with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 1999;892:119–26.10.1111/j.1749-6632.1999.tb07790.xSearch in Google Scholar PubMed
26. Senthil Kumar SP, Shen M, Spicer EG, Goudjo-Ako AJ, Stumph JD, Zhang J, Shi H. Distinct metabolic effects following short-term exposure of different high-fat diets in male and female mice. Endocr J 2014. [Epub ahead of print] doi: 10.1507/endocrj.EJ13-0455.10.1507/endocrj.EJ13-0455Search in Google Scholar PubMed PubMed Central
27. Shi H, Seeley RJ, Clegg DJ. Sexual differences in the control of energy homeostasis. Front Neuroendocrinol 2009;30:396–404.10.1016/j.yfrne.2009.03.004Search in Google Scholar PubMed PubMed Central
28. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci (Lond) 2002;102:151–66.10.1042/CS20010197Search in Google Scholar
29. Pettersson US, Waldén TB, Carlsson PO, Jansson L, Phillipson M. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLOS ONE 2012;7:e46057.10.1371/journal.pone.0046057Search in Google Scholar PubMed PubMed Central
30. Foryst-Ludwig A, Kintscher U. Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 2010;122:74–81.10.1016/j.jsbmb.2010.06.012Search in Google Scholar PubMed
31. Walmer DK, Wrona MA, Hughes CL, Nelson KG. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology 1992;131:1458–66.10.1210/endo.131.3.1505477Search in Google Scholar
32. Wade GN, Gray JM. Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol Behav 1979; 22:583–93.10.1016/0031-9384(79)90028-3Search in Google Scholar
33. McElroy JF, Wade GN. Short- and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in rats. Physiol Behav 1987;39:361–5.10.1016/0031-9384(87)90235-6Search in Google Scholar
34. Wade GN. Some effects of ovarian hormones on food intake and body weight in female rats. J Comp Physiol Psychol 1975;88:183–93.10.1037/h0076186Search in Google Scholar
35. Lund-Pero M, Jeppson B, Arneklo-Nobin B, Sjögren HO, Holmgren K, Pero RW. Non-specific steroidal esterase activity and distribution in human and other mammalian tissues. Clin Chim Acta 1994;224:9–20.10.1016/0009-8981(94)90116-3Search in Google Scholar
36. Thammacharoen S, Geary N, Lutz TA, Ogawa S, Asarian L. Divergent effects of estradiol and the estrogen receptor-[alpha] agonist PPT on eating and activation of PVN CRH neurons in ovariectomized rats and mice. Brain Res 2009;1268:88–96.10.1016/j.brainres.2009.02.067Search in Google Scholar PubMed
37. Asarian L, Geary N. Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized rats. Horm Behav 2002;42:461–71.10.1006/hbeh.2002.1835Search in Google Scholar PubMed
38. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171–6.10.1172/JCI10583Search in Google Scholar PubMed PubMed Central
39. Shi H, Davis JF, Woods SC, Seeley RJ, Clegg DJ, Benoit SC. Estrogen enhances sucrose pellet reinforcement. Appetite 2009;52:857.10.1016/j.appet.2009.04.177Search in Google Scholar
40. Shi H, Senthil Kumar SPD. Sex differences in obesity-related glucose intolerance and insulin resistance. In: Chackrewarthy S, editor. Glucose tolerance. Rijeka, Croatia: InTech, 2012:37–66.Search in Google Scholar
41. Bailey CJ, Ahmed-Sorour H. Role of ovarian hormones in the long-term control of glucose homeostasis. Diabetologia 1980;19:475–81.10.1007/BF00281829Search in Google Scholar PubMed
42. Zhu L, Brown WC, Cai Q, Krust A, Chambon P, McGuinness OP, Stafford JM. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes 2013;62:424–34.10.2337/db11-1718Search in Google Scholar PubMed PubMed Central
43. Guerre-Millo M, Leturque A, Girard J, Lavau M. Increased insulin sensitivity and responsiveness of glucose metabolism in adipocytes from female versus male rats. J Clin Invest 1985;76:109–16.10.1172/JCI111932Search in Google Scholar PubMed PubMed Central
44. Macotela Y, Boucher J, Tran TT, Kahn CR. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 2009;58:803–12.10.2337/db08-1054Search in Google Scholar PubMed PubMed Central
45. Muraki K, Okuya S, Tanizawa Y. Estrogen receptor alpha regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytes. Endocr J 2006;53:841–51.10.1507/endocrj.K06-005Search in Google Scholar
46. Koricanac G, Milosavljevic T, Stojiljkovic M, Zakula Z, Ribarac-Stepic N, Isenovic ER. Insulin signaling in the liver and uterus of ovariectomized rats treated with estradiol. J Steroid Biochem Mol Biol 2008;108:109–16.10.1016/j.jsbmb.2007.06.001Search in Google Scholar PubMed
47. Shi H, Sorrell JE, Clegg DJ, Woods SC, Seeley RJ. The roles of leptin receptors on POMC neurons in the regulation of sex-specific energy homeostasis. Physiol Behav 2010;100:165–72.10.1016/j.physbeh.2010.02.018Search in Google Scholar PubMed PubMed Central
48. Ghisletti S, Meda C, Maggi A, Vegeto E. 17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol Cell Biol 2005;25:2957–68.10.1128/MCB.25.8.2957-2968.2005Search in Google Scholar PubMed PubMed Central
49. Ji Y, Sun S, Xia S, Yang L, Li X, Qi L. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem 2012;287:24378–86.10.1074/jbc.M112.371807Search in Google Scholar PubMed PubMed Central
50. Shi H, Senthil Kumar SPD, Liu X. G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci 2013;114:193–250.10.1016/B978-0-12-386933-3.00006-6Search in Google Scholar PubMed PubMed Central
©2014 by Walter de Gruyter Berlin/Boston
